Arrayit Corporation Logo

Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.  - Powerful Science for Life™

Diagnostics - VIP Microarray Technology

Arrayit is changing the way human disease is managed by providing powerful platforms for genotyping, protein screening, testing, and diagnostics. Arrayit technology leverages the inherent aspects of microarray technology to miniaturize, multiplex and automate testing. arrayit_diagnostics_healthcareThe result is a series of tests for conceivably all 6,000 known human diseases that provide affordable, pre-symptomatic health care information for preventative medicine.

Arrayit offers VIP™ (Variation Identification Platform™) technology for human disease screening, blood typing, parentage testing, forensics, human leukocyte antigen (HLA) analysis, and infectious disease diagnosis. In one embodiment of VIP™ technology, amplified DNA samples from many different patients are printed into a microarray, and screened for genetic variations of interest. Arrayit’s VIP™ microarrays screen as many as 100,000 patients in a single test. The patented VIP™ approach greatly reduces cost by amortizing the procedure over many patients, and improves testing accuracy by utilizing a single synthetic testing mixture on all of the patient samples. Arrayit VIP™ technology can be used to screen patients for genetic diseases, neonatal disorders, infectious diseases, and any other trait that has a DNA basis. VIP™ tests are currently are being developed for cystic fibrosis, sickle cell anemia, and dozens of serious diseases that are treatable by early detection. The Arrayit approach can also be used to identify disease carriers and for forensics, food safety testing, parentage testing, HLA screening, blood typing and anti-terrorism analysis. Our children, grandchildren, and generations to come will benefit from this exciting new technology that leverages the Human Genome Project and innovative platform.  Arrayit offers a full line of products and services to empower pharmaceutical companies, hospitals, public health departments, clinical laboratories, and universities to develop genetic screening and diagnostic tests that are fast, affordable, and highly accurate. Arrayit technology also enables florescent and colorimetric detection of protein markers for protein screening, testing and diagnostics.





Copyright 1993-2019 Arrayit Corporation. All rights reserved.